No Data
No Data
Is Viatris Inc. (VTRS) the Best Weight Loss Drug Stock to Buy According to Analysts?
Over 60% of Companies Post EPS Beats This Week-Earnings Scorecard
Wall Street Today: Market Ends Wild Political TV Day in the Green
Barclays Adjusts Price Target on Viatris to $9 From $12, Keeps Underweight Rating
Why Viatris Inc. (VTRS) Went Down on Thursday
Daily short sale tracking: Petroleo Brasileiro SA Petrobras's short volume increased by 15 million, with a short sale ratio of 28%